Open access peer-reviewed chapter

Introductory Chapter: Norovirus

By Gyula Mózsik

Reviewed: June 21st 2021Published: September 1st 2021

DOI: 10.5772/intechopen.98995

Downloaded: 27

1. Introduction

Acute gastroenteritis is a major global health problem and is one of the most common infectious diseases among humans [1, 2].

Despite advances in health technology and management, this diarrhoeal illness remains a common cause of morbidity and mortality [3, 4, 5] worldwide. It affects 4.5 billion people and causes 3.5–5 million deaths each year, the majority of which occur in people in developing countries [2, 6, 7]. Acute gastroenteritis leads to approximately 2.5 million deaths annually in children younger than five years in developing countries [8].

Human enteric viruses account for more than half of all cases of gastroenteritis worldwide. There are five common viral agents of gastroenteritis: norovirus, rotavirus, adenovirus (group F types 40, 41), astrovirus, and sapovirus. Norwalk virus is the prototype strain of norovirus, which was associated with an outbreak of gastroenteritis at an elementary school in Norwalk, Ohio, in 1968. Albert Kapikian discovered norovirus as the etiological agent of this outbreak in 1972 [9].

Norovirus results in about 685 million cases of disease and 200,000 deaths annually (“Norovirus Worldwide” (https//web.archiveorg/web/201812071427/https:cdc.gov/norovirus/worldwide html) CDC 15 December 2017. Achieved from the original (https:/www.cdc.gov.norovirus/worldwide.html) on 7 December 2018. Retrieved. 29 December 2017) and Nada [10].

Advertisement

2. A brief overview of transimission, symptoms, common treatments and prevention

Norovirus (sometimes referred to as the “winter vomiting bug”) is the most common cause of gastroenteritis. Symptoms of norovirus infection include nausea, vomiting, watery diarrhea, abdominal pain, and in some cases loss of taste. Headaches, fever, general lethargy, weakness, and muscle aches may also occur. The symptoms usually develop 12–48 h after exposure, and recovery takes 1–3 days.

The disease is usually self-limiting and severe illness is rare. Although having norovirus can be unpleasant, it is not dangerous and most who contract it fully recover within a few days. In severe cases, persistent infection can lead to norovirus-associated enteropathy, intestinal villous atrophy, and absorption syndromes.

Noroviruses are transmitted directly from person to person. Norovirus infection occurs in outbreaks, especially among those living in close quarters. The virus usually spread via the fecal–oral route through contaminated food or water.

Prevention involves proper hand washing and disinfection of contaminated surfaces. Alcohol-based hand sanitizers are not effective against the norovirus, according to the National Health Service (NHS). There is no vaccine or specific treatment for norovirus. Management involves supportive treatment such as drinking sufficient fluids or receiving intravenous liquids. Oral dehydration solutions are preferred and drinks without caffeine or alcohol can help. It must be emphasized that vaccination is the only real possibility to combat this infectious disease. This is where the help of virologists, pediatricians, internists, geriatricians, clinical pharmacologists, pharmacists, chemists, and others is desperately needed.

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Gyula Mózsik (September 1st 2021). Introductory Chapter: Norovirus, Norovirus, Gyula Mózsik, IntechOpen, DOI: 10.5772/intechopen.98995. Available from:

chapter statistics

27total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Optimization, Validation and Standardization of ELISA

By Rajna Minic and Irena Zivkovic

Related Book

First chapter

Diagnosis of Gastritis – Review from Early Pathological Evaluation to Present Day Management

By Imre Laszlo Szabo, Kata Cseko, Jozsef Czimmer and Gyula Mozsik

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us